首页> 外国专利> METHOD OF TREATING OPERABLE ADENOCARCINOMA OF DUODENUM

METHOD OF TREATING OPERABLE ADENOCARCINOMA OF DUODENUM

机译:治疗十二指肠可手术腺癌的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating operable duodenum adenocarcinoma. Method involves surgical removal of the tumor and chemotherapy. No earlier than two days before surgical removal, neoadjuvant chemotherapy is performed by intra-arterial bolus administration of 50 mg/m2 abraxane in its suspension in no more than 3 ml of lipidol through a catheter inserted into a gastroduodenal artery. Catheter is then reinserted into celiac and 5-fluorouracil is introduced in amount of 1,000 mg/m2 for one hour and additionally 50 mg/m2 oxaliplatin for 30 minutes. Thereafter, no later than 4 weeks after surgical removal of the tumor, adjuvant chemotherapy with capecitabine is administered orally daily at 2,500 mg/m2 per day in 2 doses in the morning and in the evening for no more than 14 days, while taking capecitabine once a month for not more than 4 months.;EFFECT: method provides reduced total toxic effect on patient's body due to regional administration of chemopreparations.;1 cl, 1 ex
机译:技术领域本发明涉及医学,即肿瘤学,可用于治疗可手术的十二指肠腺癌。方法包括手术切除肿瘤和化学疗法。在不进行外科手术切除的两天前,通过插入其导管中的动脉内推注50 mg / m 2 甲氧沙林悬浮液中的不超过3 ml脂质体来进行新辅助化疗。胃十二指肠动脉。然后将导管重新插入腹腔,并以1,000 mg / m 2 的量引入5-氟尿嘧啶1小时,然后再以50 mg / m 2 的奥沙利铂引入30分钟。此后,在手术切除肿瘤后不迟于4周,每天早晨和晚上以2剂每天口服2,500 mg / m 2 的卡培他滨辅助化疗。少于14天,而每月一次服用卡培他滨不超过4个月。;效果:由于化学制剂的局部给药,该方法减少了对患者身体的总毒性作用。1cl,1 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号